Evidence map›Paper›PMID 36717893›Full record

ArticleJournal of translational medicine2023

Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study.

Eloi Gagnon, Patricia L Mitchell, Hasanga D Manikpurage, Erik Abner, Nele Taba, Tõnu Esko, Nooshin Ghodsian, Sébastien Thériault, Patrick Mathieu, Benoit J Arsenault

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Causal relationship between gut microbiota and diabetes based on Mendelian randomization.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  19. Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Eloi GagnonCentre de Recherche de L'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Y-3106, Pavillon Marguerite D'Youville, 2725 Chemin Ste-Foy, Québec, (QC), G1V 4G5, Canada.ORCID 0000-0002-7483-1371
Patricia L MitchellCentre de Recherche de L'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Y-3106, Pavillon Marguerite D'Youville, 2725 Chemin Ste-Foy, Québec, (QC), G1V 4G5, Canada.ORCID 0000-0002-0773-1047
Hasanga D ManikpurageCentre de Recherche de L'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Y-3106, Pavillon Marguerite D'Youville, 2725 Chemin Ste-Foy, Québec, (QC), G1V 4G5, Canada.ORCID 0000-0002-2365-6956
Erik AbnerEstonian Genome Center, Institute of Genomics, University of Tartu, Riia 23B, 51010, Tartu, Estonia.ORCID 0000-0002-6529-3161
Nele TabaEstonian Genome Center, Institute of Genomics, University of Tartu, Riia 23B, 51010, Tartu, Estonia.
Tõnu EskoEstonian Genome Center, Institute of Genomics, University of Tartu, Riia 23B, 51010, Tartu, Estonia.ORCID 0000-0003-1982-6569
Nooshin GhodsianCentre de Recherche de L'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Y-3106, Pavillon Marguerite D'Youville, 2725 Chemin Ste-Foy, Québec, (QC), G1V 4G5, Canada.ORCID 0000-0003-2042-6001
Sébastien ThériaultCentre de Recherche de L'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Y-3106, Pavillon Marguerite D'Youville, 2725 Chemin Ste-Foy, Québec, (QC), G1V 4G5, Canada.ORCID 0000-0003-1893-8307
Patrick MathieuCentre de Recherche de L'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Y-3106, Pavillon Marguerite D'Youville, 2725 Chemin Ste-Foy, Québec, (QC), G1V 4G5, Canada.
Benoit J ArsenaultCentre de Recherche de L'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Y-3106, Pavillon Marguerite D'Youville, 2725 Chemin Ste-Foy, Québec, (QC), G1V 4G5, Canada. benoit.arsenault@criucpq.ulaval.ca.ORCID 0000-0003-2240-8456
Institut universitaire de cardiologie et de pneumologie de Québec · CAUniversity of Tartu · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Features of the gut microbiota have been associated with several chronic diseases and longevity in preclinical models as well as in observational studies. Whether these relations underlie causal effects in humans remains to be established. We aimed to determine whether the gut microbiota influences cardiometabolic traits as well as the risk of chronic diseases and human longevity using a comprehensive 2-Sample Mendelian randomization approach. We included as exposures 10 gut-associated metabolites and pathways and 57 microbial taxa abundance. We included as outcomes nine cardiometabolic traits (fasting glucose, fasting insulin, systolic blood pressure, diastolic blood pressure, HDL cholesterol, LDL cholesterol, triglycerides, estimated glomerular filtration rate, body mass index [BMI]), eight chronic diseases previously linked with the gut microbiota in observational studies (Alzheimer's disease, depression, type 2 diabetes, non-alcoholic fatty liver disease, coronary artery disease (CAD), stroke, osteoporosis and chronic kidney disease), as well as parental lifespan and longevity. We found 7 associations with evidence of causality before and after sensitivity analyses, but not after multiple testing correction (1198 tests). Most effect sizes (4/7) were small. The two largest exposure-outcome effects were markedly attenuated towards the null upon inclusion of BMI or alcohol intake frequency in multivariable MR analyses. While finding robust genetic instruments for microbiota features is challenging hence potentially inflating type 2 errors, these results do not support a large causal impact of human gut microbita features on cardiometabolic traits, chronic diseases or longevity. These results also suggest that the previously documented associations between gut microbiota and human health outcomes may not always underly causal relations.

Indexed as

Coronary Artery DiseaseDiabetes Mellitus, Type 2Gastrointestinal MicrobiomeBody Mass IndexChronic DiseaseGenome-Wide Association StudyHumansLongevityMendelian Randomization AnalysisPolymorphism, Single Nucleotide

Identifiers

PMID36717893
PMCPMC9887809
OpenAlexW4318485501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.